文献速递湿疹皮炎与荨麻疹

医用粘合剂过敏原:北美接触性皮炎组2001-2018年横断面数据的回顾性分析

Medical adhesive allergens: Retrospective analysis of cross-sectional data from the North American Contact Dermatitis Group, 2001-2018.
PubMed 文献 · J Am Acad Dermatol · 2021-12-05

该回顾性研究分析了北美接触性皮炎组2001至2018年间43722例接受斑贴试验的患者,其中313例(0.7%)符合医用粘合剂过敏性接触性皮炎标准。最常见筛查系列过敏原为松香(80.7%),25.2%的患者对补充过敏原/材料呈阳性反应,17.3%仅对补充过敏原/材料反应。作者认为评估疑似医用粘合剂过敏时应检测补充过敏原和材料。

要点

  • 医用粘合剂过敏患者313例(0.7%),男性可能性较低(OR 0.58),年龄>40岁可能性较低(OR 0.76)。
  • 最常见筛查系列过敏原为松香(80.7%),其次为秘鲁香脂(3.9%)、甲基丙烯酸2-羟乙酯(2.7%)和卡巴混合物(2.7%)。
  • 25.2%的患者对补充过敏原/材料呈阳性,17.3%仅对补充过敏原/材料反应。

核心结论

  • 松香是最常见的过敏原,评估疑似医用粘合剂过敏性接触性皮炎时应检测补充过敏原和材料。

研究设计与样本

  • 回顾性研究,纳入北美接触性皮炎组2001至2018年间接受斑贴试验的43722例患者,其中313例(0.7%)符合医用粘合剂过敏性接触性皮炎标准。

主要发现

  • 医用粘合剂过敏患者相比其他过敏性接触性皮炎患者,男性可能性较低(OR 0.58,95%CI 0.45-0.77),年龄>40岁可能性较低(OR 0.76,95%CI 0.60-0.96)。
  • 最常见筛查系列过敏原为松香(80.7%)、秘鲁香脂(3.9%)、甲基丙烯酸2-羟乙酯(2.7%)和卡巴混合物(2.7%)。
  • 25.2%(79/313)的患者对补充过敏原/材料呈阳性反应,17.3%(54/313)的患者仅对补充过敏原/材料呈阳性反应。

临床怎么用

  • 原文结论建议在评估疑似医用粘合剂过敏性接触性皮炎时检测补充过敏原和材料。

局限性

  • 全面的斑贴试验结果可能存在转诊人群选择偏倚,可能不能代表一般皮肤科人群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Identification of allergens causing medical adhesive contact allergy is difficult. OBJECTIVE: To characterize the demographics, clinical characteristics, patch test results, and occupational data for North American Contact Dermatitis Group patients with medical adhesive contact allergy. METHODS: A retrospective study of 43,722 North American Contact Dermatitis Group patients patch tested from 2001 to 2018 with medical adhesive (tapes/bandaids/adhesive aids/suture glue) sources, positive patch test results, and final primary diagnoses of allergic contact dermatitis. RESULTS: In total, 313 (0.7%) patients met the inclusion criteria. Compared with other patients with final primary diagnoses of allergic contact dermatitis, patients with a medical adhesive allergy were less likely to be male (odds ratio, 0.58; 95% CI, 0.45-0.77) and/or aged >40 years (odds ratio, 0.76; 95% CI, 0.60-0.96). The most common North American Contact Dermatitis Group screening series allergens were colophony (80.7%), balsam of Peru (3.9%), 2-hydroxyethyl methacrylate (2.7%), and carba mix (2.7%). One-fourth of the patients (79/313, 25.2%) had positive patch test reactions to supplemental allergens/materials, and 54 (17.3%) of the 313 patients only had reactions to supplemental allergens/materials. LIMITATIONS: Results of comprehensive patch testing may be prone to referral population selection bias and may not be representative of the general dermatology population. CONCLUSION: Colophony was the most common allergen. Supplemental allergens and materials should be tested in the evaluation of a suspected medical adhesive contact allergy.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Atwater AR, Bembry R, Liu B, et al. Medical adhesive allergens: Retrospective analysis of cross-sectional data from the North American Contact Dermatitis Group, 2001-2018. J Am Acad Dermatol. 2021. PMID: 34875303. doi:10.1016/j.jaad.2021.11.055

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。